Cargando…

The Purinergic Landscape of Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Lung cancer is the most prevalent cancer worldwide with poor overall survival despite many new therapeutic strategies. We discuss in this review the ability of the purinergic landscape to constitute a new potent strategy in the treatment of lung cancer. After defining lung cancer and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janho dit Hreich, Serena, Benzaquen, Jonathan, Hofman, Paul, Vouret-Craviari, Valérie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025794/ https://www.ncbi.nlm.nih.gov/pubmed/35454832 http://dx.doi.org/10.3390/cancers14081926

Ejemplares similares

The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
por: Janho dit Hreich, Serena, et al.
Publicado: (2023)

Protocol for Evaluating In Vivo the Activation of the P2RX7 Immunomodulator
por: Janho dit Hreich, Serena, et al.
Publicado: (2023)

Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
por: Benzaquen, Jonathan, et al.
Publicado: (2019)

P2RX7B is a new theranostic marker for lung adenocarcinoma patients
por: Benzaquen, Jonathan, et al.
Publicado: (2020)

A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
por: Douguet, Laetitia, et al.
Publicado: (2021)

Microbes-induced EMT at the crossroad of inflammation and cancer
por: Hofman, Paul, et al.
Publicado: (2012)

Up-Regulation of Intestinal Vascular Endothelial Growth Factor by Afa/Dr Diffusely Adhering Escherichia coli
por: Cane, Gaëlle, et al.
Publicado: (2007)

HIF1A regulates xenophagic degradation of adherent and invasive Escherichia coli (AIEC)
por: Mimouna, Sanda, et al.
Publicado: (2015)

A Novel Screen for Expression Regulators of the Telomeric Protein TRF2 Identified Small Molecules That Impair TRF2 Dependent Immunosuppression and Tumor Growth
por: El Maï, Mounir, et al.
Publicado: (2021)

Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
por: Liu, Dingxie, et al.
Publicado: (2022)

MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma
por: Bozec, Alexandre, et al.
Publicado: (2017)

Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches
por: Bontoux, Christophe, et al.
Publicado: (2022)

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
por: Khatir, Wassila, et al.
Publicado: (2022)

Subversion of Autophagy in Adherent Invasive Escherichia coli-Infected Neutrophils Induces Inflammation and Cell Death
por: Chargui, Abderrahman, et al.
Publicado: (2012)

Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
por: Pujol, Nina, et al.
Publicado: (2022)

The Purinergic Landscape of Type 2 Diabetes Mellitus
por: Garcia-Jacobo, Rocio Edith, et al.
Publicado: (2022)

Lung Cancer Screening, towards a Multidimensional Approach: Why and How?
por: Benzaquen, Jonathan, et al.
Publicado: (2019)

Tumor immunity landscape in non-small cell lung cancer
por: Yu, Xiaoqing, et al.
Publicado: (2018)

Resectable non-small cell lung cancer: an evolving landscape
por: Loh, Jerold, et al.
Publicado: (2022)

Changing the landscape of non-small cell lung cancer disparities
por: Odera, Joab O., et al.
Publicado: (2021)

Stenting in Non-Small Cell Lung Cancer: How Does It Affect the Outcomes?
por: Karim, Nagla Abdel, et al.
Publicado: (2020)

The Circular RNA Landscape of Non-Small Cell Lung Cancer Cells
por: Van Der Steen, Nele, et al.
Publicado: (2020)

Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
por: Ilié, Marius, et al.
Publicado: (2022)

In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients
por: Heeke, Simon, et al.
Publicado: (2019)

Current treatment landscape for oligometastatic non-small cell lung cancer
por: Garde-Noguera, Javier, et al.
Publicado: (2022)

The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
por: Yuan, Min, et al.
Publicado: (2019)

Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
por: Lim, Sun Min, et al.
Publicado: (2020)

Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer
por: Wei, Xue‐Wu, et al.
Publicado: (2020)

The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer
por: Gristina, Valerio, et al.
Publicado: (2020)

The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer
por: Chang, Ya-Sian, et al.
Publicado: (2021)

The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis
por: Zhang, Qi, et al.
Publicado: (2022)

Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases
por: Huang, Richard S P, et al.
Publicado: (2022)

A landscape of response to drug combinations in non-small cell lung cancer
por: Nair, Nishanth Ulhas, et al.
Publicado: (2023)

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay
por: Heeke, Simon, et al.
Publicado: (2021)

Purinergic Signaling in the Hallmarks of Cancer
por: Campos-Contreras, Anaí del Rocío, et al.
Publicado: (2020)

Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer
por: Ivanina Foureau, Anna V., et al.
Publicado: (2022)

New insights into the interaction of the immune system with non-small cell lung carcinomas
por: Hofman, Paul
Publicado: (2020)

Purinergic cotransmission
por: Burnstock, Geoffrey
Publicado: (2009)

Control of Gut Inflammation by Modulation of Purinergic Signaling
por: Vuerich, Marta, et al.
Publicado: (2020)

Purinergic signalling and immune cells
por: Burnstock, Geoffrey, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j89v0i01mnvgbsqo4uj1v2i16r